OSTX logo

OSTX OS Therapies Incorporated

New York Stock Exchange Arca · Biotechnology · Healthcare

$0.81
-0.01 (-1.05%)

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide link…

Market Cap: $42.46Mostherapies.com

Price

No data yet.

Social Signal Score

33
5d
—
30d
23
1 mentions
—
60d
38
4 mentions
—
90d
38
4 mentions
—
news: 4

Analyst Ratings

4 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 0Sell 0Strong Sell 0

Revenue

$0.00
$0.00
Dec 2021Sep 2026

Analyst Estimates

FY2025
$-0.69
$-0.72–$-0.65
3 analysts
FY2026
$-0.77
$-0.79–$-0.75
2 analysts
FY2027
$-0.14
$-0.32–$0.05
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Paul A. Romness
Sector
Healthcare
Industry
Biotechnology
Employees
5
Beta
-0.64
Country
US
Piotroski score
1 / 9 (Weak)
Altman Z-score
-36.52
ostherapies.com